| - GRCh37:
- Chr2:174123399
- GRCh38:
- Chr2:173258671
| MAP3K20, MAP3K20-AS1 | | not provided, Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome
| Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:174094500
- GRCh38:
- Chr2:173229772
| MAP3K20, MAP3K20-AS1 | | Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome, not provided
| Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:174128513
- GRCh38:
- Chr2:173263785
| MAP3K20, MAP3K20-AS1 | S531L | Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome, not provided
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:174055731
- GRCh38:
- Chr2:173191003
| MAP3K20 | | Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome, not provided
| Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:174123409-174123414
- GRCh38:
- Chr2:173258681-173258686
| MAP3K20, MAP3K20-AS1 | | not provided, Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:174068513
- GRCh38:
- Chr2:173203785
| MAP3K20-AS1, MAP3K20 | | Split-foot malformation-mesoaxial polydactyly syndrome, Myopathy, centronuclear, 6, with fiber-type disproportion, not provided
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:174047614-174047615
- GRCh38:
- Chr2:173182886-173182887
| MAP3K20 | N95* | Myopathy, centronuclear, 6, with fiber-type disproportion | Pathogenic (Nov 7, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr2:174055838
- GRCh38:
- Chr2:173191110
| MAP3K20 | W172* | not provided | Pathogenic (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:174055813-174055814
- GRCh38:
- Chr2:173191085-173191086
| MAP3K20 | M164fs | Myopathy, centronuclear, 6, with fiber-type disproportion | Pathogenic (Nov 7, 2017) | no assertion criteria provided |